Skip to Content
MilliporeSigma

Key Documents

View All Documentation

Skip To

1A01040

USP

11-Ketofluticasone Propionate

Pharmaceutical Analytical Impurity (PAI)

Synonym(s):

6alpha, 9-difluoro-17- [[(fluoromethyl)sulfanyl] carbonyl]-16alpha-methyl-3,11-dioxoandrosta-1-4dien-17alpha-yl-propanoate, (6S,8S,9R,10S,13S,14S,16R,17R)-6,9-Difluoro-17-(((fluoromethyl)thio) carbonyl)-10,13,16-trimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate, (6S,8S,9R,10S,13S,14S,16R,17R)-6,9-Difluoro-17-(((fluoromethyl)thio)carbonyl)-10,13,16-trimethyl-3,11-dioxo6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice

About This Item

Empirical Formula (Hill Notation):
C25H29F3O5S
CAS Number:
1219174-94-3
Molecular Weight:
498.55
MDL number:
MFCD11226893
NACRES:
NA.24
UNSPSC Code:
41116107
Pricing and availability is not currently available.
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

pharmaceutical analytical impurity (PAI)

agency

USP

API family

fluticasone

manufacturer/tradename

USP

application(s)

pharmaceutical

format

neat

storage temp.

2-8°C

General description

Fluticasone Related Compound F is a USP Pharmaceutical Analytical Impurity (PAI).

USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.

Associated Drug Substance: Fluticasone Propionate

Therapeutic Area: Steroids

For more information about this PAI, visit here.

Application

Fluticasone Related Compound F (USP PAI) is intended for use in analytical testing to detect, identify, and measure pharmaceutical impurities.

Features and Benefits

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:

1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

Other Notes

Sales restrictions may apply.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Related Content

Patrones de referencia de la Farmacopea estadounidense

Haga su pedido de una amplia gama de materiales de referencia primarios muy caracterizados para utilizar con las monografías de la USP-NF pensadas para el análisis de sustancias farmacológicas y formas de administración, excipientes farmacéuticos, ingredientes y suplementos alimentarios.

USP Compendial Reference Standards

Order from a broad range of highly characterized primary reference standard materials to use with USP-NF monographs for the testing of drug substances & dosage forms, pharmaceutical excipients, food ingredients and dietary supplements.

Global Trade Item Number

SKUGTIN
1A01040-25MG04065269079699